CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells

被引：6

作者：

Samain, Remi ^{[1
]}

Maiques, Oscar ^{[1
]}

Monger, Joanne ^{[1
]}

Lam, Hoyin ^{[2
,3
]}

Candido, Juliana ^{[1
,4
]}

George, Samantha ^{[1
]}

Ferrari, Nicola ^{[5
,6
]}

Kohihammer, Leonie ^{[1
]}

Lunetto, Sophia ^{[7
]}

Varela, Adrian ^{[1
]}

Orgaz, Jose L. ^{[1
,8
]}

Vilardell, Felip ^{[9
]}

Olsina, Jorge Juan ^{[10
]}

Matias-Guiu, Xavier ^{[9
,11
]}

Sarker, Debashis ^{[2
]}

Biddle, Adrian ^{[7
]}

Balkwill, Frances R. ^{[1
]}

Eyles, Jim ^{[4
]}

Wilkinson, Robert W. ^{[4
]}

Kocher, Hemant M. ^{[12
,13
]}

Calvo, Fernando ^{[5
,14
]}

Wells, Claire M. ^{[2
]}

Sanz-Moreno, Victoria ^{[1
,15
]}

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Microenvironm, Charterhouse Sq, London EC1M 6BQ, England

[2] Kings Coll London, Sch Canc & Pharmaceut Sci, London SE1 1UL, England

[3] GSK, R&D Portfolio, Strategy & Business Insights, GSK House,980 Great West Rd, Brentford TW8 9GS, England

[4] AstraZeneca, Oncol R&D, Cambridge CB21 6GH, England

[5] Inst Canc Res, Tumour Microenvironm Team, 237 Fulham Rd, London SW3 6JB, England

[6] AstraZeneca, Translat Sci & Expt Med, Early Resp & Immunol, BioPharmaceut R&D, Cambridge, England

[7] Queen Mary Univ London, Blizard Inst, Ctr Cell Biol & Cutaneous Res, London E1 2AT, England

[8] UAM, Inst Invest Biomed Sols Morreale CSIC, Madrid 28029, Spain

[9] Univ Lleida, Hosp Univ Arnau Vilanova, Dept Pathol, Lleida, Spain

[10] Univ Lleida, Univ Hosp Arnau Vilanova, Dept Surg, Lleida, Spain

[11] Univ Hospita Bellvitge, IRBLLEIDA, IDIBELL, CIBERONC, Lleida, Spain

[12] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, Charterhouse Sq, London EC1M 6BQ, England

[13] Royal London Hosp, Barts Hlth NHS Trust, Barts & London HPB Ctr, London, England

[14] Inst Biomed & Biotecnol Cantabria, C Albert Einstein 22,E39011, Santander, Spain

[15] Breast Canc NowToby Robins Res Ctr, Inst Canc Res, Cytoskeleton & Canc Metastasis Team, 237 Fulham Rd, London SW3 6JB, England

来源：

SCIENCE ADVANCES | 2023年 / 9卷 / 42期

关键词：

DUCTAL ADENOCARCINOMA; T-CELLS; TUMOR; ROCK; PLASTICITY; ADENOSINE; PROMOTES; GENERATION; INHIBITORS; EXPRESSION;

D O I：

10.1126/sciadv.adi0244

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) has a very poor prognosis because of its high propensity to metastasize and its immunosuppressive microenvironment. Using a panel of pancreatic cancer cell lines, three-dimensional (3D) invasion systems, microarray gene signatures, microfluidic devices, mouse models, and intravital imaging, we demonstrate that ROCK-Myosin II activity in PDAC cells supports a transcriptional program conferring amoeboid invasive and immunosuppressive traits and in vivo metastatic abilities. Moreover, we find that immune checkpoint CD73 is highly expressed in amoeboid PDAC cells and drives their invasive, metastatic, and immunomodulatory traits. Mechanistically, CD73 activates RhoA-ROCK-Myosin II downstream of PI3K. Tissue microarrays of human PDAC biopsies combined with bioinformatic analysis reveal that rounded-amoeboid invasive cells with high CD73-ROCK-Myosin II activity and their immunosuppressive microenvironment confer poor prognosis to patients. We propose targeting amoeboid PDAC cells as a therapeutic strategy.

引用

页数：19

共 8 条

[1] CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism
Liu, Weishuai
Yu, Xiaozhou
Yuan, Yudong
Feng, Yixing
Wu, Chao
Huang, Chongbiao
Xie, Peng
Li, Shengnan
Li, Xiaofeng
Wang, Ziyang
Qi, Lisha
Chen, Yanan
Shi, Lei
Li, Mulin Jun
Huang, Zhiyong
Tang, Bo
Chang, Antao
Hao, Jihui
ADVANCED SCIENCE, 2023, 10 (06)
[2] Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner
Tang, Tianyu
Huang, Xing
Lu, Minghao
Zhang, Gang
Han, Xu
Liang, Tingbo
NATURE COMMUNICATIONS, 2023, 14 (01)
[3] CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis
King, Ryan J.
Shukla, Surendra K.
He, Chunbo
Vernucci, Enza
Thakur, Ravi
Attri, Kuldeep S.
Dasgupta, Aneesha
Chaika, Nina V.
Mulder, Scott E.
Abrego, Jaime
Murthy, Divya
Gunda, Venugopal
Pacheco, Camila G.
Grandgenett, Paul M.
Lazenby, Audrey J.
Hollingsworth, Michael A.
Yu, Fang
Mehla, Kamiya
Singh, Pankaj K.
ONCOGENE, 2022, 41 (07) : 971 - 982
[4] Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
Terp, Mikkel G.
Olesen, Kristina A.
Arnspang, Eva C.
Lund, Rikke R.
Lagerholm, B. Christoffer
Ditzel, Henrik J.
Leth-Larsen, Rikke
JOURNAL OF IMMUNOLOGY, 2013, 191 (08) : 4165 - 4173
[5] Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State
Nguyen, Anna M.
Zhou, Jianhong
Sicairos, Brihget
Sonney, Sangeetha
Du, Yuchun
MOLECULAR & CELLULAR PROTEOMICS, 2020, 19 (02) : 375 - 389
[6] Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Based Synergistic Therapy for Pancreatic Cancer
Chen, Qiangda
Yin, Hanlin
He, Junyi
Xie, Yuqi
Wang, Wenquan
Xu, Huaxiang
Zhang, Lei
Shi, Chenye
Yu, Jun
Wu, Wenchuan
Liu, Liang
Pu, Ning
Lou, Wenhui
ADVANCED SCIENCE, 2023, 10 (33)
[7] Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation
Cadassou, Octavia
Raza, Muhammad-Zawwad
Machon, Christelle
Gudefin, Laura
Armanet, Celia
Chettab, Kamel
Guitton, Jerome
Tozzi, Maria Grazia
Dumontet, Charles
Cros-Perrial, Emeline
Jordheim, Lars Petter
CELLULAR ONCOLOGY, 2021, 44 (01) : 151 - 165
[8] Overexpression of Ecto-5′-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix
Zhou, Ping
Zhi, Xiuling
Zhou, Tingting
Chen, Sifeng
Li, Xiaobo
Wang, Li
Yin, Lianhua
Shao, Zhimin
Ou, Zhouluo
CANCER BIOLOGY & THERAPY, 2007, 6 (03) : 426 - 431

← 1 →